人口統計,傾向,および米国におけるカポシ肉腫患者の心血管死亡率:監視,疫学,および最終結果データベースの分析
Rozi Khan1, Abdul Qahar Khan Yasinzai2, Aman Goyal3
1University of Pittsburgh Medical Center, Division of Internal Medicine Harrisburg Pennsylvania USA.
Health science reports
|September 2, 2025
まとめ
心血管疾患による死亡は,特に女性およびヒスパニック系の人々の間で,カポシ肉腫 (KS) 患者において重大な懸念事項である. この研究では,米国におけるKSの死亡傾向と人口統計を分析した.
科学分野:
- 腫瘍学
- 流行病学
- 心血管科学
背景:
- カポシ肉腫 (KS) はヒトヘルペスウイルス-8に関連した血管性腫瘍である.
- KS患者の死亡原因,特に心血管疾患による死亡に関するデータは限られている.
- この研究は,米国におけるKSの死亡傾向を調査することで,このギャップを埋めています.
研究 の 目的:
- カポシ肉腫の発生率と死亡率の年間傾向を分析する.
- カポシ肉腫と診断された患者の人口分析を行う.
- カポシ肉腫患者の主要な死因を特定し,心臓血管疾患による死亡率に重点を置く.
主な方法:
- 監視,疫学,最終結果 (SEER) データベースを利用した.
- 2000年から2020年までの 17のがん登録記録のデータを収集した.
- カポシ肉腫と診断された患者数は8247人.
主要な成果:
- カポシ・サルコマの発生率は全体的に減少したが,女性,ヒスパニック系,黒人集団では著しく減少しなかった.
- 生存率は,皮膚性KSと比較して,内臓性KSでは低かった.
- 感染症 (49. 8%) と心血管疾患 (11. 4%) が主な死因であり,女性およびヒスパニック系患者の心血管疾患による死亡率は高かった.
結論:
- カポシ・サルコマの発生率は,人口グループによって異なる傾向を示しています.
- 心血管疾患による死亡率はカポシ肉腫患者の死亡における重要な要因であり,女性とヒスパニック系の人々を不釣り合いに影響する.
- この発見は,カポシ・サルコマの治療における標的型心血管リスク評価と管理の必要性を強調しています.
関連する概念動画
Kaplan-Meier Approach
258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
Assumptions of Survival Analysis
196
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
196
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Assessment of the Cardiovascular System I: Subjective Data
467
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
467


